Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank80
3Y CAGR-84.2%
5Y CAGR-63.7%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
-84.2%/yr
Quarterly compound
5Y CAGR
-63.7%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 1.44% |
| Q2 2025 | 1.45% |
| Q1 2025 | 1.44% |
| Q4 2024 | 1.44% |
| Q3 2024 | 1.43% |
| Q2 2024 | 1.43% |
| Q1 2024 | 1.41% |
| Q4 2023 | 1.46% |
| Q3 2023 | 1.40% |
| Q2 2023 | 1.28% |
| Q1 2023 | 1894.74% |
| Q4 2022 | -3.41% |
| Q3 2022 | 366.37% |
| Q2 2022 | -12.36% |
| Q1 2022 | -9.60% |
| Q4 2021 | -8.88% |
| Q3 2021 | -7.93% |
| Q2 2021 | -6.20% |
| Q1 2021 | -5.74% |
| Q4 2020 | -1.16% |
| Q3 2020 | 229.41% |
| Q2 2020 | -18.36% |
| Q1 2020 | -31.13% |
| Q4 2019 | -11.68% |
| Q3 2019 | 146.61% |
| Q2 2019 | -13.24% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |